178 related articles for article (PubMed ID: 12580897)
1. Vascular endothelial growth factor-B and retinal vascular development in the mouse.
Reichelt M; Shi S; Hayes M; Kay G; Batch J; Gole GA; Browning J
Clin Exp Ophthalmol; 2003 Feb; 31(1):61-5. PubMed ID: 12580897
[TBL] [Abstract][Full Text] [Related]
2. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Pierce EA; Foley ED; Smith LE
Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
[TBL] [Abstract][Full Text] [Related]
3. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.
Stone J; Chan-Ling T; Pe'er J; Itin A; Gnessin H; Keshet E
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):290-9. PubMed ID: 8603833
[TBL] [Abstract][Full Text] [Related]
4. ICAM-1 depletion does not alter retinal vascular development in a model of oxygen-mediated neovascularization.
Kociok N; Radetzky S; Krohne TU; Gavranic C; Liang Y; Semkova I; Joussen AM
Exp Eye Res; 2009 Oct; 89(4):503-10. PubMed ID: 19482023
[TBL] [Abstract][Full Text] [Related]
5. Vitreal macrophages express vascular endothelial growth factor in oxygen-induced retinopathy.
Naug HL; Browning J; Gole GA; Gobé G
Clin Exp Ophthalmol; 2000 Feb; 28(1):48-52. PubMed ID: 11345346
[TBL] [Abstract][Full Text] [Related]
6. The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP.
Leske DA; Wu J; Fautsch MP; Karger RA; Berdahl JP; Lanier WL; Holmes JM
Mol Vis; 2004 Jan; 10():43-50. PubMed ID: 14758338
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP.
Miyamoto N; Mandai M; Takagi H; Suzuma I; Suzuma K; Koyama S; Otani A; Oh H; Honda Y
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2007-14. PubMed ID: 12037012
[TBL] [Abstract][Full Text] [Related]
8. [Expression of mRNA of vascular endothelial growth factor in a rat model of hyperoxia-induced retinopathy].
Zhang ZH; Jiang L; Qiao LX
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):371-4. PubMed ID: 17706045
[TBL] [Abstract][Full Text] [Related]
9. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
10. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.
Zhang W; Yokota H; Xu Z; Narayanan SP; Yancey L; Yoshida A; Marcus DM; Caldwell RW; Caldwell RB; Brooks SE
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6384-95. PubMed ID: 21705685
[TBL] [Abstract][Full Text] [Related]
11. c-abl is required for the development of hyperoxia-induced retinopathy.
Nunes I; Higgins RD; Zanetta L; Shamamian P; Goff SP
J Exp Med; 2001 Jun; 193(12):1383-91. PubMed ID: 11413193
[TBL] [Abstract][Full Text] [Related]
12. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat.
Dorey CK; Aouididi S; Reynaud X; Dvorak HF; Brown LF
Arch Ophthalmol; 1996 Oct; 114(10):1210-7. PubMed ID: 8859080
[TBL] [Abstract][Full Text] [Related]
13. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.
Budd SJ; Thompson H; Hartnett ME
Arch Ophthalmol; 2010 Aug; 128(8):1014-21. PubMed ID: 20697002
[TBL] [Abstract][Full Text] [Related]
14. IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.
Lofqvist C; Chen J; Connor KM; Smith AC; Aderman CM; Liu N; Pintar JE; Ludwig T; Hellstrom A; Smith LE
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10589-94. PubMed ID: 17567756
[TBL] [Abstract][Full Text] [Related]
15. The relationship of retinal VEGF and retinal IGF-1 mRNA with neovascularization in an acidosis-induced model of retinopathy of prematurity.
Leske DA; Wu J; Mookadam M; Chen Y; Fautsch MP; Holmes JM; Lanier WL
Curr Eye Res; 2006 Feb; 31(2):163-9. PubMed ID: 16500767
[TBL] [Abstract][Full Text] [Related]
16. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).
Scott A; Powner MB; Fruttiger M
Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725
[TBL] [Abstract][Full Text] [Related]
17. Captopril and vascular endothelial growth factor in a mouse model of retinopathy.
Higgins RD; Yan Y; Geng Y; Sharma J; Barr SM
Curr Eye Res; 2003 Aug; 27(2):123-9. PubMed ID: 14632165
[TBL] [Abstract][Full Text] [Related]
18. Effect(s) of preterm birth on normal retinal vascular development and oxygen-induced retinopathy in the neonatal rat.
Li R; Yang X; Wang Y; Chu Z; Liu T; Zhu T; Gao X; Ma Z
Curr Eye Res; 2013 Dec; 38(12):1266-73. PubMed ID: 23885967
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and the eye. Past, present and future.
Aiello LP
Arch Ophthalmol; 1996 Oct; 114(10):1252-4. PubMed ID: 8859087
[No Abstract] [Full Text] [Related]
20. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy.
Taomoto M; McLeod DS; Merges C; Lutty GA
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):230-43. PubMed ID: 10634625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
